发明名称
摘要 PURPOSE:To provide a new compound having a strong angiotensin II antagonistic activity and an antihypertensive activity and useful as a therapeutic agent for circulatory organ diseases such as hypertension, cardiac diseases, cerebral hemorrhage. etc. CONSTITUTION:A compound of formula I [R is (substituted)hydrocarbon residue; R<2>, R<3> are H, cyano, nitro, (substituted lower alkyl, etc.; R<2>, R<3> are combined with each other to form a (substituted)benzene ring; Y is N, CH; Z is group of formula II (R<4> is H, halogen, nitro; R<5> is group capable of forming an anion, etc.; X is a direct bond, a bond combined through a spacer having a two or less atomic chain; (n) is 1,2); the broken line exhibits the existence of a double bond]. For example, 2-n-butyl-3-[[2'-(N-methoxymethyltetrazol-5-yl)biphenyl-4- yl]methyl]-4(3H)-quinazoline. The compound of formula I is obtained e.g. by dehydratively condensing a compound of formula III with a compound of formula IV.
申请公布号 JP3114073(B2) 申请公布日期 2000.12.04
申请号 JP19910123230 申请日期 1991.03.06
申请人 发明人
分类号 A61K31/435;A61K31/4418;A61K31/4425;A61K31/4427;A61K31/4433;A61K31/4436;A61K31/4439;A61K31/505;A61K31/517;A61P9/00;A61P9/12;A61P43/00;C07D211/86;C07D211/90;C07D213/68;C07D213/78;C07D239/22;C07D239/36;C07D239/88;C07D401/10;C07D403/10;C07D409/04;(IPC1-7):C07D211/86;A61K31/442;A61K31/443 主分类号 A61K31/435
代理机构 代理人
主权项
地址